Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1729 studies found for:    Open Studies | "Breast Diseases"
Show Display Options
Rank Status Study
21 Recruiting Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer
Conditions: Breast Cancer;   Breast Cancer Surgery
Intervention: Device: Positron Emission Mammography (PEM)
22 Unknown  Women At Risk: The High Risk Breast Cancer Program
Condition: Breast Cancer
Intervention:
23 Recruiting Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer
Condition: Early Stage Breast Carcinoma
Interventions: Device: implanted port for chemo administration (X-port isp);   Device: Use of a PICC line for chemo administration (PowerPICC SOLO²)
24 Recruiting Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer;   Melanoma;   Renal Cell Carcinoma;   Triple-negative Breast Cancer;   Head and Neck Cancer;   Bladder Cancer;   Non-small Cell Lung Cancer
Intervention: Biological: MGA271
25 Recruiting Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
Conditions: Breast Cancer;   Solid Tumors
Interventions: Drug: Everolimus;   Drug: Trastuzumab;   Drug: Letrozole
26 Recruiting Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients
Conditions: Anxiety Disorder;   Depression;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Psychosocial Effects of Cancer and Its Treatment;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Other: educational intervention;   Other: counseling intervention;   Other: psychosocial support for caregiver;   Other: questionnaire administration;   Other: laboratory biomarker analysis
27 Unknown  Computed Tomography Laser Mammography Breast Imaging Device
Condition: Breast Cancer
Intervention:
28 Recruiting Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation
Condition: Invasive Breast Cancer
Interventions: Other: Eucerin;   Other: Mometasone Furoate 0.1%
29 Recruiting Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: therapeutic conventional surgery;   Radiation: whole breast irradiation
30 Not yet recruiting Molecular Triaging and Diagnostic Imaging to Guide Neoadjuvant Therapy
Condition: Breast Cancer
Interventions: Drug: Anthracycline Based Chemotherapy;   Procedure: Ultrasound
31 Recruiting A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
Condition: Advanced Breast Cancer
Intervention: Drug: selatinib ditosilate tablets
32 Recruiting Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Tegafur Gimeracil Oteracil Potassium Capsule
33 Recruiting Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer
Condition: HER2 Negative Metastatic Breast Cancer
Intervention: Drug: ADI-PEG 20
34 Recruiting Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Trastuzumab QW, Trastuzumab Q3W
35 Recruiting Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
Conditions: Adult Cholangiocarcinoma;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma;   BCLC Stage D Adult Hepatocellular Carcinoma;   Hilar Cholangiocarcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma;   Recurrent Childhood Liver Cancer;   Recurrent Extrahepatic Bile Duct Carcinoma;   Recurrent Gallbladder Carcinoma;   Stage II Gallbladder Cancer;   Stage III Childhood Hepatocellular Carcinoma;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Childhood Hepatocellular Carcinoma;   Stage IV Distal Bile Duct Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Trametinib;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Drug: Capecitabine;   Other: Laboratory Biomarker Analysis
36 Recruiting Aromatase Inhibitor Host Factors Study
Condition: Breast Neoplasms
Intervention: Drug: Letrozole
37 Recruiting A Safety Study of SGN-LIV1A in Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: SGN-LIV1A
38 Recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
39 Recruiting Ultrasound-based Breast Cancer Screening in Chinese Women
Condition: Breast Cancer
Intervention: Other: ultrasound plus clinical breast examination
40 Recruiting Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
Condition: Breast Cancer
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years